Gynecologic Cancer Education: PARP Inhibitor Therapy

PARP Inhibitors in Ovarian Cancer Treatment: Understanding Side EffectsПодробнее

Advances in Endometrial Carcinoma Treatment: The Power of Immunotherapy and Other Emerging RegimensПодробнее

Clinical Advances in Ovarian Cancer: Exploring the Expanding Role of PARP Inhibitors in the Treat...Подробнее

Coping with Gynecologic Cancer Treatment Related Side Effects - Dr. Theresa ShaoПодробнее

PARP inhibitors in ovarian cancer: Clinical updates from SGO 2023Подробнее

What’s New with PARP Inhibitors and Ovarian Cancer?Подробнее

Episode 227: Biomarker Testing, PARP Inhibitors, and Oral Adherence During Ovarian Cancer Mainten...Подробнее

Let’s Talk Ovarian Cancer: Management of PARP Inhibitor Maintenance Treatment in PatientsПодробнее

The ABCs of ADCs: Ovarian Cancer and Antibody Drug ConjugatesПодробнее

Precision Medicine in Oncology: Ep.9 DEBATE - Is PARP inhibitor maintenance therapy in first-line...Подробнее

Modern, Molecularly Informed Therapy for Patients With Advanced Endometrial CancerПодробнее

Personalizing Advanced Ovarian Cancer Treatment With PARP Inhibitors and Novel ApproachesПодробнее

Molecular Classification of Endometrial Cancer and Targeted Therapy ConsiderationsПодробнее

Dr. Melissa Hardesty: The State of GYN Cancer in AlaskaПодробнее

Ovarian Cancer Treatments, Research and Survivorship Updates 2022Подробнее

Ovarian Cancer: Oncologist answers 5 questions about risk factors, screening & treatment | StanfordПодробнее

abc Oncology Educational Course 2022 - Gynecological CancersПодробнее

Optimizing the Use of PARP Inhibitors in Ovarian CancerПодробнее

Gynecologic Oncology at ASCO 2022: ATHENA–MONO Trial (Rucaparib Monotherapy) for Ovarian CancerПодробнее

PARP inhibitors as first-line maintenance therapy in ovarian cancerПодробнее